Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "merck co"

Merck & Co., Inc (MRK) Q1 Earnings: What to Expect?
Bidness Etc

Merck Lower After Mixed Q1 Report

Merck & Co., Inc. (NYSE: MRK ) shares are trading lower by $1.16 at $53.65 in Thursday's session. Despite an EPS beat of $0.04, the Street is concerned with its slight revenue miss. Following a lower open, it could only manage a $0.03 pop to ..., 17 hours ago

Why Merck, Whole Foods Market & Other Stocks Are in Spotlight Today?

The US Stock market is trading higher on Thursday, helped by a 3% growth in Brent and WTI. Meanwhile, the earnings season is still in progress and among the companies that have posted their results are Merck & Co., Inc. (NYSE : MRK ) , Whole Foods ...
 InsiderMonkey.com18 hours ago Merck & Co's 1st-qtr revenues hit by generic competition  Pharma Letter13 hours ago MARKET SNAPSHOT: S&P 500, Dow End Little Changed Ahead Of Jobs Report; Nasdaq Logs A Loss  Nasdaq14 hours ago MARKET SNAPSHOT : U.S. Stocks Try To Avoid 3-day Slide A Day Ahead Of Jobs Report  4 Traders15 hours ago

Merck 1Q Profit Beats, Raises Forecast

Merck & Co reported better-than-expected profit in the first quarter, driven by higher sales of its diabetes drug Januvia and heart drug Zetia. The company also raised its full-year adjusted earnings forecast and narrowed its revenue forecast to ...
 FOXBusiness.com23 hours ago Merck sales disappoint as Januvia, Remicade fall short  Reuters23 hours ago MERCK : posts better-than-expected profit, raises forecast  4 Traders23 hours ago Merck quarterly profit up 18 pct  Sharenet1 day ago

Merck Quarterly Sales Slip Again as Some Older Drugs Disappoint

Revenue dropped 1.2%; analysts predicted an increase of 1% Earnings beat estimates on cost-cutting, Keytruda sales Merck & Co.'s first-quarter revenue fell short of analysts estimates, extending a four-year decline as sales of older drugs like ...
 Bloomberg19 hours ago Merck Earnings Top Estimates Even Though Sales Slip Again (1)  La Repubblica22 hours ago Merck Earnings Top Expectations Even Though Sales Slip Again  La Repubblica23 hours ago

BRIEF-Merck says EU Zepatier launch may be delayed

May 5 Merck & Co Inc * Says European launch of its new Zepatier hepatitis C drug may may be delayed until late 2016 or 2017 after EU regulator cited inadequate record-keeping by a third party manufacturer Source text for Eikon: Further company ...
 Reuters UK21 hours ago BRIEF-Merck says EU manufacturer of Zepatier cited for recordkeeping lapses  Reuters UK21 hours ago

Merck & Co. (MRK) Kenneth C. Frazier on Q1 2016 Results - Earnings Call Transcript

Merck & Co., Inc. (NYSE: MRK ) Q1 2016 Earnings Call May 05, 2016 8:00 am ET Executives Teri Loxam - Vice President, Investor Relations Kenneth C. Frazier - Chairman, President & Chief Executive Officer Robert M. Davis - Chief ...
 Seeking Alpha17 hours ago 8-K - Merck & Co., Inc. (0000310158) (Filer)  SEC Filings1 day ago Merck & Co Q1 16 Earnings Conference Call At 8:00 AM ET  Nasdaq1 day ago

Merck's Q1 Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast

Merck & Co., Inc. (NYSE: MRK ) reported 18 percent increase in net income to $1.13 billion in the first quarter from $958 million in the year-ago quarter. Similarly, its earnings advanced 21 percent to $0.40 a share from $0.33 a share in the ...
 Benzinga.com23 hours ago Merck (MRK) Beats Q1 EPS Forecast, Misses on Revenues  Equilibrio Informativo18 hours ago

Mid-Morning Market Update: Markets Edge Higher; Merck Profit Beats Views

Following the market opening Thursday, the Dow traded up 0.13 percent to 17,673.38 while the NASDAQ gained 0.06 percent to 4,728.57. The S&P also rose, gaining 0.11 percent to 2,053.31. Leading and Lagging Sectors On Thursday, the energy ...
 Benzinga.com21 hours ago

Investors Disappointed as Merck & Co. Sales of Januvia and Remicade Fall Short

Merck Announces First-Quarter 2016 Financial Results First-Quarter 2016 GAAP EPS was $0.40; First-Quarter Non-GAAP EPS Increased by 5 Percent to $0.89 Company Continues to Expect 2016 Full-Year GAAP EPS to be Between $1.96 and $2.23; Narrows and ...
 BioSpace20 hours ago Merck to Present at the Deutsche Bank 41st Annual Health Care Conference  Business Wire1 day ago Merck Announces First-Quarter 2016 Financial Results  TMC Net20 hours ago Merck & Co. Announces First-Quarter 2016 Financial Results  BioSpace17 hours ago

Merck Global Health hires new head of VC investments

-Merck Global Health Innovation Fund, the venture investment arm of Merck & Co (known as MSD in Europe and Canada), has appointed Francesca Domenech Wuttke, Ph.D. as a managing director. Dr. Wuttke will lead venture capital investments, focusing on ...
 FirstWord Pharma13 hours ago Merck & Co.'s first-quarter profit rises, as sales drop  FirstWord Pharma23 hours ago 7 Figures That Sum Up Merck & Co.'s First Quarter  FOXBusiness.com19 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less